// App-Quantinova.ai

: Impact on Survival of the Introduction of New Therapies for Relapsed-Refractory Aggressive B-Cell Lymphoma, Based on the Relinf Registry: A Study By the Spanish Geltamo Group

Researchers

Presenter

  • Mariana Bastos-Oreiro

Principal Investigators

  • Ana Jimenez-Ubieto

  • Sonia Gonzalez de Villambrosia

  • Raul Cordoba

  • Elena Perez Ceballos

  • Eva Maria Donato Martin

  • Ana Muntañola Prat

  • Hugo Daniel Luzardo Henriquez

  • Lourdes Escoda

  • Maria Jesus Penarrubia

  • Maria Pozas

  • Alberto Lopez-Garcia

  • Daniel Garcia

  • Emilia Pardal

  • Claudia Salazar Lozada

  • Alejandro Martin Garcia-Sancho

Medical Centers

  • GELTAMO, Hospital Doce de Octubre, Madrid, Spain

  • Hospital Dr Peset, VALENCIA, ESP

  • Hematology Department, Hospital Sanitas La Zarzuela, Madrid, Spain

  • Hematology Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain

  • Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain

  • Hematology Department, ICO - Hospital Joan XXIII, Tarragona, Spain

  • Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Spain

  • Hospital Clinico Universitario de Valladolid, Valladolid, Spain

  • Hematology, Hospital de Octubre, Madrid, Spain

  • Hematology, Hospital Universitario Morales Meseguer, Murcia, Spain

  • Hematology and Hemotherapy, Hospital Virgen del Puerto, Plasencia, Spain

  • Hospital Universitari Mutua Terrassa, Barcelona, Spain

  • Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain

  • Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

  • Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain

  • Hematology department, Hospital IVO, Valencia, Spain

Locations

  • Spain

  • Venezuela

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved